Cargando…
Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection
A mouse model of spontaneous latent tuberculosis infection (LTBI) that mimics LTBI in humans is valuable for drug/vaccine development and the study of tuberculosis. However, most LTBI mouse models require interventions, and a spontaneous LTBI mouse model with a low bacterial load is difficult to est...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705449/ https://www.ncbi.nlm.nih.gov/pubmed/26779146 http://dx.doi.org/10.3389/fmicb.2015.01490 |
_version_ | 1782409014882074624 |
---|---|
author | Zhan, Lingjun Tang, Jun Lin, Shuzhu Xu, Yanfeng Xu, Yuhuan Qin, Chuan |
author_facet | Zhan, Lingjun Tang, Jun Lin, Shuzhu Xu, Yanfeng Xu, Yuhuan Qin, Chuan |
author_sort | Zhan, Lingjun |
collection | PubMed |
description | A mouse model of spontaneous latent tuberculosis infection (LTBI) that mimics LTBI in humans is valuable for drug/vaccine development and the study of tuberculosis. However, most LTBI mouse models require interventions, and a spontaneous LTBI mouse model with a low bacterial load is difficult to establish. In this study, mice were IV-inoculated with 100 CFU Mycobacterium tuberculosis H37Rv, and a persistent LTBI was established with low bacterial loads (0.5~1.5log(10) CFU in the lung; < 4log(10) CFU in the spleen). Histopathological changes in the lung and spleen were mild during the first 20 weeks post-inoculation. The model was used to demonstrate the comparative effects of prophylactic and therapeutic administration of Ganoderma lucidum extract (spores and spores lipid) in preventing H37Rv replication in both lung and spleen. H37Rv was inhibited with prophylactic use of G. lucidum extract relative to that of the untreated control and therapy groups, and observed in the spleen and lung as early as post-inoculation week 3 and week 5 respectively. H37Rv infection in the therapy group was comparable to that of the untreated control mice. No significant mitigation of pathological changes was observed in either the prophylactic or therapeutic group. Our results suggest that this new LTBI mouse model is an efficient tool of testing anti-tuberculosis drug, the use of G. lucidum extract prior to M. tuberculosis infection may protect the host against bacterial replication to some extent. |
format | Online Article Text |
id | pubmed-4705449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-47054492016-01-15 Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection Zhan, Lingjun Tang, Jun Lin, Shuzhu Xu, Yanfeng Xu, Yuhuan Qin, Chuan Front Microbiol Public Health A mouse model of spontaneous latent tuberculosis infection (LTBI) that mimics LTBI in humans is valuable for drug/vaccine development and the study of tuberculosis. However, most LTBI mouse models require interventions, and a spontaneous LTBI mouse model with a low bacterial load is difficult to establish. In this study, mice were IV-inoculated with 100 CFU Mycobacterium tuberculosis H37Rv, and a persistent LTBI was established with low bacterial loads (0.5~1.5log(10) CFU in the lung; < 4log(10) CFU in the spleen). Histopathological changes in the lung and spleen were mild during the first 20 weeks post-inoculation. The model was used to demonstrate the comparative effects of prophylactic and therapeutic administration of Ganoderma lucidum extract (spores and spores lipid) in preventing H37Rv replication in both lung and spleen. H37Rv was inhibited with prophylactic use of G. lucidum extract relative to that of the untreated control and therapy groups, and observed in the spleen and lung as early as post-inoculation week 3 and week 5 respectively. H37Rv infection in the therapy group was comparable to that of the untreated control mice. No significant mitigation of pathological changes was observed in either the prophylactic or therapeutic group. Our results suggest that this new LTBI mouse model is an efficient tool of testing anti-tuberculosis drug, the use of G. lucidum extract prior to M. tuberculosis infection may protect the host against bacterial replication to some extent. Frontiers Media S.A. 2016-01-08 /pmc/articles/PMC4705449/ /pubmed/26779146 http://dx.doi.org/10.3389/fmicb.2015.01490 Text en Copyright © 2016 Zhan, Tang, Lin, Xu, Xu and Qin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Zhan, Lingjun Tang, Jun Lin, Shuzhu Xu, Yanfeng Xu, Yuhuan Qin, Chuan Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection |
title | Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection |
title_full | Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection |
title_fullStr | Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection |
title_full_unstemmed | Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection |
title_short | Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection |
title_sort | prophylactic use of ganoderma lucidum extract may inhibit mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infection |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705449/ https://www.ncbi.nlm.nih.gov/pubmed/26779146 http://dx.doi.org/10.3389/fmicb.2015.01490 |
work_keys_str_mv | AT zhanlingjun prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection AT tangjun prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection AT linshuzhu prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection AT xuyanfeng prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection AT xuyuhuan prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection AT qinchuan prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection |